These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27525363)

  • 1. Rosuvastatin decreases testosterone levels but not sexual function in men with type 2 diabetes.
    Hsieh CJ; Huang B
    Diabetes Res Clin Pract; 2016 Oct; 120():81-8. PubMed ID: 27525363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin.
    Baspınar O; Bayram F; Korkmaz S; Aksu M; Kocer D; Dizdar OS; Simsek Y; Toth PP
    J Clin Lipidol; 2016; 10(6):1452-1461. PubMed ID: 27919363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial.
    Nishikido T; Oyama J; Keida T; Ohira H; Node K
    J Cardiol; 2016 Apr; 67(4):340-6. PubMed ID: 26162946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD
    Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFICACY OF 5 MG AND 10 MG ROSUVASTATIN IN TYPE-2 DIABETES MELLITUS WITH HYPERCHOLESTEROALEMIA.
    Ullah F; Afridi AK; Rahim F; ur Rahman S; Ashfaq M
    J Ayub Med Coll Abbottabad; 2015; 27(3):564-8. PubMed ID: 26721008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
    Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results.
    Barge-Caballero G; Barge-Caballero E; Marzoa-Rivas R; Paniagua-Martín MJ; Barrio-Rodríguez A; Naya-Leira C; Blanco-Canosa P; Grille-Cancela Z; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Transpl Int; 2015 Sep; 28(9):1034-41. PubMed ID: 25864881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men.
    Haffner SM; Laakso M; Miettinen H; Mykkänen L; Karhapää P; Rainwater DL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3697-701. PubMed ID: 8855825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
    Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ezetimibe-statin combination on steroid hormone production in men with coronary artery disease and low cholesterol levels.
    Krysiak R; Kowalska B; Żmuda W; Okopień B
    Pharmacol Rep; 2015 Apr; 67(2):305-9. PubMed ID: 25712655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study.
    de Keyser CE; de Lima FV; de Jong FH; Hofman A; de Rijke YB; Uitterlinden AG; Visser LE; Stricker BH
    Eur J Endocrinol; 2015 Aug; 173(2):155-65. PubMed ID: 26034077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol, statins, and longevity from age 70 to 90 years.
    Jacobs JM; Cohen A; Ein-Mor E; Stessman J
    J Am Med Dir Assoc; 2013 Dec; 14(12):883-8. PubMed ID: 24094647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.
    Mazza F; Stefanutti C; Di Giacomo S; Vivenzio A; Fraone N; Mazzarella B; Bucci A
    Am J Cardiovasc Drugs; 2008; 8(4):265-70. PubMed ID: 18690760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.
    Stegman B; Shao M; Nicholls SJ; Elshazly M; Cho L; King P; Kapadia S; Tuzcu M; Nissen SE; Puri R
    Atherosclerosis; 2016 Nov; 254():78-84. PubMed ID: 27710808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.